Rajkumar SV - Search Results

1

Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.

Ghobrial IM, Dispenzieri A, Bundy KL, Gastineau DA, Rajkumar SV, Therneau TM, Lacy MQ, Witzig TE, Litzow MR, Christensen BR, Hayman S, Pribula CG, Gertz MA. Ghobrial IM, et al. Among authors: rajkumar sv. Bone Marrow Transplant. 2003 Sep;32(6):587-92. doi: 10.1038/sj.bmt.1704173. Bone Marrow Transplant. 2003. PMID: 12953131

2

Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.

Rajkumar SV, Gertz MA, Kyle RA. Rajkumar SV, et al. Am J Med. 1998 Mar;104(3):232-7. doi: 10.1016/s0002-9343(98)00037-0. Am J Med. 1998. PMID: 9552085

3

Primary systemic amyloidosis with delayed progression to multiple myeloma.

Rajkumar SV, Gertz MA, Kyle RA. Rajkumar SV, et al. Cancer. 1998 Apr 15;82(8):1501-5. Cancer. 1998. PMID: 9554527

4

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. Rajkumar SV, et al. Leukemia. 1999 Mar;13(3):469-72. doi: 10.1038/sj.leu.2401336. Leukemia. 1999. PMID: 10086738

5

Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA, Litzow MR, Gertz MA, Greipp PR. Rajkumar SV, et al. J Clin Oncol. 1999 May;17(5):1551-7. doi: 10.1200/JCO.1999.17.5.1551. J Clin Oncol. 1999. PMID: 10334543

6

Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Rajkumar SV, et al. Bone Marrow Transplant. 1999 Jun;23(12):1261-6. doi: 10.1038/sj.bmt.1701787. Bone Marrow Transplant. 1999. PMID: 10414913 Clinical Trial.

7

Autologous stem cell transplantation for relapsed and primary refractory myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Rajkumar SV, et al. Bone Marrow Transplant. 1999 Jun;23(12):1267-72. doi: 10.1038/sj.bmt.1701805. Bone Marrow Transplant. 1999. PMID: 10414914 Clinical Trial.

8

Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.

Rajkumar SV, Fonseca R, Dewald GW, Therneau TM, Lacy MQ, Kyle RA, Greipp PR, Gertz MA. Rajkumar SV, et al. Cancer Genet Cytogenet. 1999 Aug;113(1):73-7. doi: 10.1016/s0165-4608(99)00009-6. Cancer Genet Cytogenet. 1999. PMID: 10459351

9

Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.

Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M. Rajkumar S, et al. Bone Marrow Transplant. 1999 Sep;24(5):497-503. doi: 10.1038/sj.bmt.1701943. Bone Marrow Transplant. 1999. PMID: 10482933

10

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.

Fonseca R, Hoyer JD, Aguayo P, Jalal SM, Ahmann GJ, Rajkumar SV, Witzig TE, Lacy MQ, Dispenzieri A, Gertz MA, Kyle RA, Greipp PR. Fonseca R, et al. Among authors: rajkumar sv. Leuk Lymphoma. 1999 Nov;35(5-6):599-605. doi: 10.1080/10428199909169625. Leuk Lymphoma. 1999. PMID: 10609798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

814 results

Search Page

Filters